Agreed, pfeifer. How many times have we seen innovative science completely let down by mediocre custodianship by managers?
Bad negotiators, self interest selling out too early or living the high life, failure to build competitive tension, fixated on one buyer, lack of partnerships, not investing themselves, failure to see the need for ongoing scientific validation, inability to get into the top tier of big pharma. I hope this isnt the case here but some of the behaviours have me worried.
The team have it in their hands now with the GVHD outcome to have our CYP MSCs accepted as the standard for all MSC related research and consequently products.
How they play the next 6 months is critical to establishing higher multiples market cap wise.
- Forums
- ASX - By Stock
- CYP
- Going forward...
Going forward..., page-2
- There are more pages in this discussion • 2,127 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYP (ASX) to my watchlist
(20min delay)
|
|||||
Last
31.0¢ |
Change
-0.020(6.06%) |
Mkt cap ! $55.68M |
Open | High | Low | Value | Volume |
33.0¢ | 33.0¢ | 30.0¢ | $3.969K | 13.12K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 40000 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 2000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 40000 | 0.295 |
1 | 7000 | 0.280 |
1 | 1854 | 0.275 |
1 | 10000 | 0.270 |
2 | 18846 | 0.260 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 2000 | 1 |
0.320 | 30000 | 2 |
0.330 | 2650 | 1 |
0.340 | 15873 | 1 |
0.345 | 28248 | 3 |
Last trade - 13.14pm 05/06/2024 (20 minute delay) ? |
|
|||||
Last
32.5¢ |
  |
Change
-0.020 ( 4.84 %) |
|||
Open | High | Low | Volume | ||
32.5¢ | 32.5¢ | 32.5¢ | 3814 | ||
Last updated 10.02am 05/06/2024 ? |
Featured News
CYP (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non-Executive Director
Simon Kidston
Non-Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online